GlassScriptPhysician profile
Salman Gohar
NPI 1477795516
$13,146.61
in general payments reported to CMS, 2019-2025
36 companies · $1,598 in 2025
The $1,598 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $943 · 2021: $1,585 · 2022: $2,402 · 2023: $2,032 · 2024: $3,586 · 2025: $1,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,418 · Travel and Lodging: $1,598 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,417.85 |
| Travel and Lodging | $1,598.32 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,906.45 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Assurity |
| Abiomed | $1,633.67 | 2019-2025 | Impella |
| Boston Scientific Corporation | $594.69 | 2020-2025 | Bodyguardian, Bodyguardian One, Watchman Flx |
| Medtronic, INC. | $465.91 | 2021-2025 | Onyx Frontier, Micra, Symplicity G3 |
| Cvrx, INC. | $451.63 | 2023-2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $334.94 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $321.88 | 2020-2025 | Onpattro, Amvuttra |
| Novartis Pharmaceuticals Corporation | $294.77 | 2019-2023 | |
| Pfizer INC. | $196.95 | 2020-2025 | |
| Koya Medical, INC. | $185.51 | 2025 | Koya Medical, Dayspring |
| Merck Sharp & Dohme LLC | $168.46 | 2021-2025 | Verquvo |
| Daiichi Sankyo INC. | $155.00 | 2020-2024 | Injectafer |
| Novo Nordisk INC | $153.20 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Actelion Pharmaceuticals US, INC. | $145.69 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.55 | 2020-2024 | Jardiance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $124.75 | 2021 | |
| Atricure, INC. | $99.90 | 2022-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Impulse Dynamics (USA) INC. | $88.66 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.53 | 2019-2024 | Lifevest |
| Inari Medical, INC. | $62.07 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Philips North America LLC | $61.52 | 2024-2025 | Extended Holter, (Ck4) Mcot |
| Getinge USA Sales, LLC | $54.17 | 2025 | Cardioroot |
| Heartflow, INC. | $51.92 | 2021-2022 | |
| United Therapeutics Corporation | $50.49 | 2021-2025 | Tyvaso |
| E.R. Squibb & Sons, L.L.C. | $50.48 | 2023-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $38.77 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Lexicon Pharmaceuticals, INC. | $38.41 | 2023-2024 | Inpefa |
| Shockwave Medical, INC | $30.27 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $30.14 | 2021-2022 | |
| Scpharmaceuticals INC. | $27.99 | 2024 | |
| Innovation Technologies INC | $24.84 | 2024 | Irrisept |
| W. L. Gore & Associates, INC. | $23.74 | 2025 | Gore Viabahn Endoprosthesis With Heparin |
| Tactile Systems Technology INC | $18.25 | 2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $16.49 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Bardy Diagnostics, INC. | $11.79 | 2022 | |
| Livanova USA, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Gohar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.